Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1995
03/15/1995EP0642791A1 Use of branched chain amino acids for the manufacture of a medicament for treating tardire dyskinesia
03/15/1995EP0642790A2 Alkali citrates and their use as medicaments, especially against arterosclerosis
03/15/1995EP0642789A1 Remedy for glaucoma
03/15/1995EP0642788A2 Tramadol salt containing medicaments with sustained release of the active ingredient
03/15/1995EP0642787A2 Cessation of tobacco use
03/15/1995EP0642786A1 Method for the manufacture of a laxative composition
03/15/1995EP0642591A1 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
03/15/1995EP0642589A1 Method and reagent for inhibiting viral replication
03/15/1995EP0642586A1 CULTURED $i(TAXUS) TISSUES AS A SOURCE OF TAXOL, RELATED TAXANES AND OTHER NOVEL ANTI-TUMOR/ANTI-VIRAL COMPOUNDS
03/15/1995EP0642584A1 Nucleic acid corresponding to a gene of chromosome 22 involved in recurrent chromosomal translocations associated with the development of cancerous tumors
03/15/1995EP0642533A1 Heparan sulphate oligosaccharides having hepatocyte growth factor binding affinity
03/15/1995EP0642532A1 Proteinoid carriers and methods for preparation and use thereof
03/15/1995EP0642529A1 11-g(b)-SUBSTITUTED 14,17-ETHANOESTRATRIENES, PROCESS FOR PREPARING THESE COMPOUNDS AND THEIR USE FOR PREPARING MEDICAMENTS.
03/15/1995EP0642521A1 Thio-substituted nitrogen-containing heterocyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
03/15/1995EP0642520A1 Thio-substituted cyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
03/15/1995EP0642519A1 Sulfur-containing phosponate compounds for treating abnormal calcium and phosphate metabolism
03/15/1995EP0642518A1 Phosphonosulfonate compounds for treating abnormal calcium and phosphate metabolism
03/15/1995EP0642517A1 Quaternary nitrogen-containing phosphonate compounds, for treating abnormal calcium and phosphate metabolism
03/15/1995EP0642516A1 Macrocyclic immunomodulators
03/15/1995EP0642515A1 New ginkgolide derivatives and a process for preparing them
03/15/1995EP0642513A1 Indolocarbazole imides and their use
03/15/1995EP0642509A1 Novel potent inducers of terminal differentiation and methods of use thereof
03/15/1995EP0642508A1 Tricyclic quinoxalinediones as glutamate receptor antagonists
03/15/1995EP0642507A1 Catalytic antibodies against cocaine and methods of using and producing same
03/15/1995EP0642504A1 (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them
03/15/1995EP0642503A1 10-desacetoxytaxol derivatives
03/15/1995EP0642501A1 Novel pilocarpine derivatives and process for their preparation
03/15/1995EP0642500A1 4-amino-3-acyl quinoline derivatives and their use as inhibitors of gastric acid secretion
03/15/1995EP0642499A1 Retinoids and their use in treating skin diseases and leukemia
03/15/1995EP0642498A1 NEW $i(N)-ARYL AND $i(N)-HETEROARYLUREA DERIVATIVES AS INHIBITORS OF ACYL COENZYME A:CHOLESTEROL ACYL TRANSFERASE (ACAT)
03/15/1995EP0642497A1 Novel n-hydroxyalkyl-substituted 1,2,3,6-tetrahydropyridine and piperidine derivatives
03/15/1995EP0642496A1 Synthetic heteroaryl polyamines as excitatory amino acid neurotransmitter antagonists
03/15/1995EP0642489A1 Cyclopentane and cyclopentene derivatives with antiallergic antiinflammatory and tumor necrosis factor inhibiting activity
03/15/1995EP0642353A1 Treatment of vascular leakage syndrome and collagenase induced disease by administration of matrix metalloproteinase inhibitors
03/15/1995EP0642347A1 Use of 2-halo adenine derivatives as therapeutic agents against chronic myelogenous leukemia
03/15/1995EP0642346A1 Solid, storage-stable, germicidal, pre-iodine composition
03/15/1995EP0642345A1 Halichondrins and related compounds
03/15/1995EP0642343A1 Treatment of cancers
03/15/1995EP0642342A1 Selective cell inactivation in blood
03/15/1995EP0642341A1 Use of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme a reductase as a modality in cancer therapy
03/15/1995EP0642340A1 Compositions based on histamine h 2?-receptor antagonists and cationic exchangers complexes
03/15/1995EP0642339A1 Dipalmitoylhydroxyproline and oleoylmethionine containing composition
03/15/1995EP0642336A1 Use of nsiad in the treatment of dementia
03/15/1995EP0642335A1 Controlled release preparation containing a salt of morphine
03/15/1995EP0573604B1 Methods for the treatment of osteoporosis
03/15/1995EP0563153B1 N-(mercaptoalkyl)amides
03/15/1995EP0535129B1 An anticoagulant preparation
03/15/1995EP0526478B1 3-indolyl thioacetate derivatives
03/15/1995EP0510028B1 Thioformamide derivatives
03/15/1995EP0433393B1 Treatment of damaged bone marrow and dosage units therefor
03/15/1995EP0394333B1 Uses of sulphated sugars
03/15/1995EP0248876B1 Process for the preparation of 1-methylamino-quinoline-carboxylic acid derivatives
03/15/1995CN1100104A New polypeptide compound and a process for preparation thereof
03/15/1995CN1100102A Method for preparing ursodeoxycholic acid using fowl gall as raw material
03/15/1995CN1100101A 14alpha-hydroxy-4-androstene-3,6,17-trione hydrate crystal and process for producing same
03/15/1995CN1100100A 1-beta-methy1-2-thiolic carbapenem derivatives
03/15/1995CN1100099A Quinolyl-dihydropyridine esters, processes for their preparation, and their use in medicaments
03/15/1995CN1100098A 2-amino-4-quinolyl-dihydropyridines, processes for their preparation, and their use
03/15/1995CN1100097A Apiolin-A use in preparation of medicine for prevention and treatment of diseases caused by cerebral ischemia
03/15/1995CN1100096A Process for the preparation of 2-Û4-|4(4-chloro-1-pyrazolyl)butyl¨1-piperazinylÙ pyrimidine (lesopitron)
03/15/1995CN1100090A Amine derivatives of oxo- and hydroxy-substituted hydrocarbons
03/15/1995CN1099973A Compound vermifuge for animals
03/15/1995CN1027905C Process for preparing jietacin
03/15/1995CN1027896C Antiviral, highly water soluble, stable, crystalline salts of 2'-3'-dideoxyinosine monohydrate, 2'3'-dideoxy-2',3'-didehydrothymidine monohydrate and 2',3'-dideoxy-2'-Fluoroinosine hemihydrate
03/15/1995CN1027895C Method for preparation and purification of mixture of glycosphingolipids free from contamination by non-conventional viruses
03/15/1995CN1027893C Pharmaceutical composition containing 1,2-dithioheterocyclicpentene-3-trione-5-oxide
03/15/1995CN1027892C Improved process for preparation of substituted indolone derivatives
03/15/1995CN1027891C 5-substituted ornithine derivatives.
03/15/1995CN1027859C Method for preparing anthelmintic cream
03/15/1995CA2132034A1 Intravenously administrable aqueous solution
03/15/1995CA2131977A1 Pharmaceutic composition for maintaining and/or restoring a near normal platelet aggregation rate
03/15/1995CA2131967A1 Substituted heterocyclylisoquinolinium salts and compositions and method of use thereof
03/15/1995CA2131966A1 Substituted 6,11-ethano-6,11-dihydrobenzo(b)quinolizinium salts and compositions and methods of use thereof
03/15/1995CA2131929A1 Laxative compositions
03/15/1995CA2128275A1 12-hetero substituted 6,11-ethano-6,11-dihydrobenzo¬b| quinolizinium salts and compositions and method of use thereof
03/14/1995USRE34878 Hypoglycemic agent
03/14/1995US5397805 Treatment liquid for reapplying (unfolding) detached retina to the chorioid of the eye
03/14/1995US5397803 Use of glutamine to reduce rate of pathogenic microorganism infection
03/14/1995US5397802 Gem-dichlorocyclopropanes as antitumor agents
03/14/1995US5397800 Gastrointestinal disorders
03/14/1995US5397799 Anxiolytic agents, antidepressants
03/14/1995US5397798 Benzamide and sulfonamide hypoglycemic agents
03/14/1995US5397797 Treatment of ocular hypertension with an ocular synergistic combination
03/14/1995US5397796 Inhibitors of platelet aggregation, metastasis of carcinoma cells and osteoclast binding to the bone surfaces
03/14/1995US5397794 Treatment of retrovirus
03/14/1995US5397792 Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
03/14/1995US5397791 Fibrinogen receptor antagonists
03/14/1995US5397790 Substituted isoquinolinyl-1-2-diaminocyclobutene-3,4,-diones
03/14/1995US5397788 Antitumor agents, antiulcer agents, antipsychotics or anxiety
03/14/1995US5397787 Vinylene-azaindole derivatives
03/14/1995US5397784 Stable parenteral compositions of vinblastine or vincristine
03/14/1995US5397783 Antidepressants, anxiolytic agents
03/14/1995US5397782 4-(Bis(halophenyl)methylene)-1-piperidinyl derivatives
03/14/1995US5397781 Pyrimidine derivatives
03/14/1995US5397778 Enteral formulations for treatment of inflammation and infection
03/14/1995US5397776 Vitamin D compounds with anti-progesterone activity
03/14/1995US5397775 26,27-dimethylene-1α,25-dihydroxyvitamin D2 and 26,27-dimethylene-24-epi-1α,25-dihydroxyvitamin D2 and methods for preparing same
03/14/1995US5397774 Pyrazolopyrimidine and pyrimidinyl bisphosphonic esters as anti-inflammatories
03/14/1995US5397703 Method for generation of antibodies to cell surface molecules
03/14/1995US5397701 Azido-substituted fatty acid analog enzyme substrates
1 ... 7035 7036 7037 7038 7039 7040 7041 7042 7043 7044 7045 7046 7047 7048 7049 7050 7051 7052 7053 7054 7055 ... 7860